STAT Plus: Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs

Amid efforts to blunt rising medicines costs, a new analysis finds three states succeeded in helping their residents save money by capping out-of-pocket costs on pricey specialty drugs and, at the same time, also managed to avoid increased spending by health plans.

Overall, out-of-pocket spending by patients fell $351 per month in Delaware, Maryland, and Louisiana, each of which passed laws that set $150 caps on what consumers must pay for prescriptions for specialty medicines. These include medications to combat such hard-to-treat maladies as multiple sclerosis, rheumatoid arthritis, and hepatitis C, among others.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs »